SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-21-003907
Filing Date
2021-11-10
Accepted
2021-11-10 07:15:50
Documents
14
Period of Report
2021-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rptx-20211110.htm   iXBRL 8-K 53253
2 EX-99.1 rptx-ex99_1.htm EX-99.1 296293
3 GRAPHIC img233743075_0.jpg GRAPHIC 3037
  Complete submission text file 0000950170-21-003907.txt   493747

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rptx-20211110.xsd EX-101.SCH 2487
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rptx-20211110_lab.xml EX-101.LAB 14530
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rptx-20211110_pre.xml EX-101.PRE 10662
7 EXTRACTED XBRL INSTANCE DOCUMENT rptx-20211110_htm.xml XML 5103
Mailing Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1
Business Address 7210 FREDERICK-BANTING, SUITE 100 ST-LAURENT A8 H4S 2A1 (857) 412-7018
Repare Therapeutics Inc. (Filer) CIK: 0001808158 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39335 | Film No.: 211394383
SIC: 2834 Pharmaceutical Preparations